| ADR Ontology |
| ADR Term |
Rosacea |
| ADR ID |
BADD_A03896 |
| ADR Hierarchy |
|
| Description |
A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7). | A variant of rosacea. [MeSH] |
| MedDRA Code |
10039218 |
| MeSH ID |
D012393; D012393; D012393
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Acne rosacea | Rosacea | Rosacea-like dermatitis | Rosacea aggravated | Acne Rosacea | Phymatous Rosacea | Rosacea, Phymatous | Ocular Rosacea | Rosacea, Ocular | Papulopustular Rosacea | Rosacea, Papulopustular | Erythematotelangiectatic Rosacea | Rosacea, Erythematotelangiectatic | Granulomatous Rosacea | Rosacea, Granulomatous |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
